Analyst Ratings for Amylyx Pharmaceuticals inc. (AMLX)
AMLX Rating Summary
AMLX Price Target Summary
- Highest: $34.00 (H.C. Wainwright)
- Lowest: $10.00 (Goldman Sachs)
- Average: $20.88
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$20.88 (+50.7%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
Avg. $ Target:
$20.88 (+50.7%)
* Over Last 12-Mos
Rating Score: 8.3 / 10
Percentile Rank: 86%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/3/2026 | Stifel | James Condulis | New Coverage | Buy (N/A) |
21.00 (N/A) |
15.17 (13.85) |
-8.7% | Details |
| 7/10/2025 | Goldman Sachs » Updated 8/27/2025 |
Corinne Johnson | New Coverage | Buy (N/A) |
10.00 (N/A) |
6.98 (13.85) |
98.42% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
